The largest database of trusted experimental protocols

Np aecm ficoll

Manufactured by Biosearch Technologies

NP-AECM-Ficoll is a protein purification resin designed for the separation and purification of biomolecules. It is composed of a Ficoll polymer matrix that is modified with N-acryloylamino-ethoxyethyl-carbamoyl-methyl groups, which provide ion exchange properties for the capture and separation of target proteins and other biomolecules.

Automatically generated - may contain errors

5 protocols using np aecm ficoll

1

Induction of T-Dependent and T-Independent Immune Responses

Check if the same lab product or an alternative is used in the 5 most similar protocols
For T-dependent immune responses, mice were immunized i.p. with 1×109 SRBCs in PBS. For T-independent type-I and type-II responses, mice were immunized i.p. with 20 μg NP-LPS or 30 μg of NP-AECM-FICOLL (both Biosearch Technologies), respectively. Peripheral blood and spleens were removed at the indicated time-points for analysis.
+ Open protocol
+ Expand
2

Immunization Protocol with Ovalbumin and Adjuvants

Check if the same lab product or an alternative is used in the 5 most similar protocols
All animal experiments were performed in accordance with the Federal and Cantonal laws of Switzerland and approved by the Cantonal Veterinary Office of Basel-Stadt. Female mice C57Bl/6NCrl were obtained from Charles River, France. All mice were used at an age of 7–11 weeks.
Mice were immunized 3 times once a week sub-cutaneously in the neck with 50 μg Ova (Invivogen) together with adjuvant AddaVax (MF59, Invivogen) at 1:5 v/v. NP-OvaL and NP-AECM-Ficoll (Biosearch Technologies) were injected at 50 μg/ mouse. Eventually the following compounds were co-injected as indicated: IVIg (Octagam 10%; Octapharma), bevacizumab (Roche) or panitumumab (Amgen). All injections volumes were completed to 600 μL with DPBS (Gibco Invitrogen). Mice were terminated 24h after the last injection and blood and organs were collected.
+ Open protocol
+ Expand
3

Induction of T-Dependent and T-Independent Immune Responses

Check if the same lab product or an alternative is used in the 5 most similar protocols
For T-dependent immune responses, mice were immunized i.p. with 1×109 SRBCs in PBS. For T-independent type-I and type-II responses, mice were immunized i.p. with 20 μg NP-LPS or 30 μg of NP-AECM-FICOLL (both Biosearch Technologies), respectively. Peripheral blood and spleens were removed at the indicated time-points for analysis.
+ Open protocol
+ Expand
4

Humoral Immune Response to rSFV-β-gal and NP-Ficoll

Check if the same lab product or an alternative is used in the 5 most similar protocols
On day 0, each mouse was i.p. immunized with 2 × 106 infectious units (IU) of rSFV vector encoding β-galactosidase (rSFV-β-gal). On day 7, each mouse was further i.p. immunized with 40 μg of NP-AECM-Ficoll (Biosearch Technologies). On day 13, blood from the sub-mandibular vein of mice was collected, and the T-dependent antibody to rSFV-β-gal (β-galactosidase specific IgG) and the T-independent antibody to NP-Ficoll (NP specific IgM) in the serum were measured by ELISA.
+ Open protocol
+ Expand
5

Immunization and Antibody Response Assay

Check if the same lab product or an alternative is used in the 5 most similar protocols
Immunization and ELISA was performed as previously described (50 (link)). On day 0, mice were i.p. immunized with either 2×106 infectious units (IU) of rSFV vector encoding β-galactosidase (rSFV-β-gal) or 40 μg of NP-AECM-Ficoll (Biosearch Technologies). On days 7 and 14, blood was collected for analysis of the antibody responses to NP-Ficoll (NP-specific IgM) and rSFV-β-gal (β-galactosidase-specific IgG) by ELISA.
ELISA analysis of IL-2 was performed according to the manufacturer’s instructions (#88–7024-22, eBioscience).
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!